Astec Lifesciences Share Price

₹ 555.00

+₹6.45 (1.18%)
1D
Last updated 03 Nov, 2026, 15:29 IST
NSE: ASTEC
|
Agrochemicals

Astec Lifesciences Share Price Today

As of 3 Nov 2026, Astec Lifesciences share price is ₹555.00. The stock opened at ₹553.00, compared to its previous close of ₹548.55. During today's trading session, Astec Lifesciences share price moved in the range of ₹544.90 to ₹575.00, with an average price of ₹559.95 for the day. Looking at its last 52-week, the stock has touched a low of ₹513.40 and a high of ₹941.75. On the performance front, Astec Lifesciences share price has declined by 21.04% over the last six months and is down 16.89% on a year-on-year basis.

Share price over the last 1 day rose from 554.95 to 555.00, ranging between 545.00 and 572.15.
₹544.90
1.18% up today
₹575.00
1D LOW
1D HIGH

Astec Lifesciences Stock Insights

Latest Earning
Op Profit TrendUp by 42.55% YoY
Latest Earning
Net Profit TrendUp by 39.96% YoY
Latest Earning
Revenue TrendUp by 17.13% YoY
Stock Performance
UnderperformingUnderperforming Nifty by 8.33 % in last 1 yr
Shareholding Pattern
DIIDII increased stake by 2.08%
Shareholding Pattern
FIIFII increased stake by 280.60%
Astec Lifesciences stock performance
Open₹553.00
High₹575.00
Low₹544.90
Prev. close₹548.55
Astec Lifesciences trading activity
Volume76,947
Average traded price₹558.03
Last traded time03:29:51 03 Nov
Last traded quantity5
Circuit
L
H
₹438.85
₹658.25
52-week
L
H
₹513.40
₹941.75
Mkt Cap Cr
1,217.53
P/E
-15.4
P/B
3.66
ROA
-10.01%
ROE
-23.77%
ROCE
-7.49%
Quick Ratio
0.61
EV/EBITDA
-334.35

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Astec Lifescienc has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Astec Lifescienc appears overvalued compared to its peers
Earnings: 3 out of 5, Neutral
Earnings
Neutral
Astec Lifescienc earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
UPL43,545.5020.131.252.3%5.54%11.23%0.856.19
PI Industries33,195.9228.492.968.67%11.76%14.62%3.5315.44
Sumitomo Chemical India16,030.0728.674.3411.23%15.12%20.13%2.6519.1
Bayer CropScience14,737.6420.134.9712.43%15.8%20.08%1.0812.57
Sharda Cropchem5,996.059.581.911.37%19.8%25.2%1.394.77
Dhanuka Agritech4,375.3614.892.5414.11%21.17%26.61%2.78.94
Rallis India3,575.3128.192.738.99%9.99%13.01%0.815.35
NACL Industries2,728.93219.814.00.91%2.49%7.39%0.8431.1
BHAGIRADHA CHEM & INDS L2,627.1095.573.762.46%2.6%4.13%1.1833.44
GSP CROP SCIENCE LIMITED2,040.5420.712.646.37%12.69%15.86%1.1510.51

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Astec Lifesciences Company Background

ISIN
INE563J01010
Sector Market Cap
₹ 1,217.53 Cr

Astec LifeSciences Limited is an India-based company, which is engaged in the manufacturing of agrochemical active ingredients (technical), bulk, formulations and intermediate products. The Company undertakes contract development and manufacturing services for a diverse range of agrochemicals. The Company operates through a single segment, namely Agrochemicals. Its product categories include Fungicide, Growth Regulator, Intermediates, Insecticide, and Herbicide. Its products include Azimsulfuron, Halosulfuron, Flutriafol, Rimsulfuron, Transfluthrin, Prothiaconazole, Metalaxyl, Cyproconazole, and Tribenuron methyl. It has a sales mix of both exports and domestic sales. It exports to approximately 17 countries, including the United States and countries across Europe, West Asia, South-East Asia, Latin America and Africa. The Company has approximately nine manufacturing plants, which are located in Maharashtra.

Astec Lifesciences Financial Highlights

  • Revenue: Astec Lifesciences reported revenue of ₹453.22 crore in FY26 vs ₹386.93 crore in FY25. It showed an increase of 17.13% on a yearly basis.
  • Operating Profit: Astec Lifesciences reported an operating loss of ₹81.00 crore in FY26 vs ₹140.99 crore in FY25. It showed an increase of 42.55% on a year-on-year basis.
  • Net Profit: Astec Lifesciences reported a net loss of ₹80.88 crore in FY26 vs ₹134.71 crore in FY25. It showed an increase of 39.96% on a yearly basis.

Astec Lifesciences Quarterly Result Highlights

  • Astec Lifesciences reported revenue of ₹72.64 crore in Sep 2026, compared with ₹84.29 crore in Jun 2026, representing a decrease of 13.82% on a quarter-on-quarter (QoQ) basis.
  • Astec Lifesciences reported an operating loss of ₹37.43 crore in Sep 2026, compared with ₹18.74 crore in Jun 2026, representing a decrease of 99.73% on a quarter-on-quarter (QoQ) basis.
  • Astec Lifesciences reported a loss of ₹37.40 crore in Sep 2026, compared with ₹18.71 crore in Jun 2026, reflecting a decrease of 99.89% on a QoQ basis.
  • The earnings per share (EPS) of Astec Lifesciences stood at ₹37.79 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
71.96%
FII
0.03%
Other DII
0.32%
Retail and other
24.67%
Mutual funds
3.02%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.04%
Mar 20260.02%
Jun 20260.01%
Sep 20260.03%

Astec Lifesciences Investment Returns

1 day
+0.55%
1 week
-15.98%
1 month
-22.59%
1 year
-16.89%
3 years
-56.19%
5 years
-58.41%

Astec Lifesciences Share Price History

Astec Lifesciences share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹542.00 / ₹548.55
+0.55%
30 Oct 26
₹582.00 / ₹545.55
-6.11%
29 Oct 26
₹598.00 / ₹581.05
-3.63%
28 Oct 26
₹644.90 / ₹602.95
-6.30%
Show more

Astec Lifesciences Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹448.15₹381.30₹458.18₹628.17
Other Income₹5.07₹5.63₹5.64₹13.06
Total Revenue₹453.22₹386.93₹463.82₹641.23
Total Expenses₹532.12₹527.92₹525.57₹606.28
Profit Before Tax-₹81.00-₹140.99-₹61.75₹34.95
Tax-₹0.12-₹6.28-₹14.86₹9.35
Profit After Tax-₹80.88-₹134.71-₹46.89₹25.59
EPS - Basic-₹37.79-₹68.71-₹23.93₹13.04
EPS - Diluted-₹37.79-₹68.71-₹23.93₹13.04

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹81.00-₹140.99-₹61.75₹34.95
Income before WC changes-₹2.21-₹39.92₹1.69₹85.45
Change in Assets-₹85.17₹35.32₹101.00₹10.12
Change in Liabilities₹7.27-₹8.80-₹90.50-₹16.03
Change in WC-₹77.90₹26.53₹10.49-₹5.91
Cash flow from Operations-₹80.71-₹8.40₹10.22₹74.66
Cash flow from Investing-₹4.31-₹15.23-₹135.18-₹112.51
Cash flow from Financing₹94.49₹23.73₹124.96₹37.77
Total Cash Flow₹9.47₹0.10₹0.00-₹0.08
Cash (Start of the year)₹0.58₹0.47₹0.47₹0.55
Cash (End of the year)₹10.05₹0.58₹0.47₹0.47

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹499.05₹540.29₹576.44₹480.56
Current Assets₹442.99₹341.14₹398.49₹498.85
Total Assets₹942.04₹881.42₹974.93₹979.41
Current Liabilities₹499.79₹365.71₹397.16₹526.20
Net Current Asset-₹56.80-₹24.57₹1.33-₹27.35
Non-Current Liabilities₹51.33₹280.69₹208.25₹33.66
Equity Capital₹390.92₹235.02₹369.52₹419.56
Total Equity & Liabilities₹942.04₹881.42₹974.93₹979.41

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹448.15₹381.30₹458.18₹628.17
Other Income₹4.99₹5.56₹5.58₹13.04
Total Revenue₹453.13₹386.86₹463.76₹641.20
Total Expenses₹532.21₹527.98₹525.64₹606.35
Profit Before Tax-₹81.17-₹141.12-₹61.88₹34.85
Tax-₹0.16-₹6.31-₹14.89₹9.33
Profit After Tax-₹81.01-₹134.81-₹46.99₹25.52
EPS - Basic-₹37.83-₹68.74-₹23.96₹13.02
EPS - Diluted-₹37.83-₹68.74-₹23.96₹13.02

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹81.17-₹141.12-₹61.88₹34.85
Income before WC changes-₹2.19-₹39.91₹1.70₹85.46
Change in Assets-₹85.07₹35.32₹100.89₹10.11
Change in Liabilities₹7.23-₹8.83-₹90.53-₹16.39
Change in WC-₹77.84₹26.48₹10.36-₹6.28
Cash flow from Operations-₹80.59-₹8.39₹10.13₹74.32
Cash flow from Investing-₹4.32-₹15.13-₹134.98-₹112.07
Cash flow from Financing₹94.38₹23.62₹124.85₹37.66
Total Cash Flow₹9.47₹0.10₹0.00-₹0.09
Cash (Start of the year)₹0.57₹0.46₹0.46₹0.54
Cash (End of the year)₹10.04₹0.57₹0.46₹0.46

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹499.56₹540.46₹576.67₹480.75
Current Assets₹441.66₹339.96₹397.48₹498.09
Total Assets₹941.22₹880.42₹974.15₹978.85
Current Liabilities₹499.78₹365.69₹397.25₹526.33
Net Current Asset-₹58.11-₹25.73₹0.23-₹28.23
Non-Current Liabilities₹51.58₹280.66₹208.22₹33.73
Equity Capital₹389.87₹234.07₹368.68₹418.79
Total Equity & Liabilities₹941.22₹880.42₹974.15₹978.85
* All values are in INR Crore
Astec Lifesciences market depth
Bid quantityBid priceAsk priceAsk quantity
00555.95175
0000
0000
0000
0000
Total bid quantity0
Total ask quantity175
Astec Lifesciences technical summary
Bearish indicators3
Neutral indicators2
Bullish indicators3
OverallNeutral
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
27.14
Bearish
ATR (14)
38.92
Neutral
STOCH(9,6)
6.26
Bullish
STOCH RSI (14)
3.04
Bullish
ADX(9)
35.44
Bearish
UO(9)
40.46
Neutral
ROC(12)
-23.95
Bearish
WillR(14)
-94.68
Bullish
Period
Simple value
Exponential vaue
5D
584.32
580.41
10D
626.95
615.72
20D
674.68
649.67
50D
665.19
666.94
100D
674.97
669.43
Volume trend — traded volume by day
3 Nov0L
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct1L
27 Oct1L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Astec Lifesciences
Agrochemicals
Add Stock
Add Another

Astec Lifesciences Returns Calculator

Top Gainers

KRBL Share Price
₹401.45
+38.45 (+10.59%)
MARICO Share Price
₹878.40
+79.85 (+10%)
BALRAMCHIN Share Price
₹654.80
+54.9 (+9.15%)
TRIDENT Share Price
₹23.79
+1.58 (+7.11%)
AEGISLOG Share Price
₹1177.10
+77 (+7%)
See more

Top Losers

KEC Share Price
₹316.35
-32.65 (-9.36%)
GNFC Share Price
₹465.05
-45.95 (-8.99%)
PRAJIND Share Price
₹254.63
-16.5 (-6.09%)
AIAENG Share Price
₹3389.70
-217.6 (-6.03%)
GESHIP Share Price
₹1536.50
-63.9 (-3.99%)
See more

Astec Lifesciences Share Price FAQs

Please be aware that Astec Lifesciences stock prices are subject to continuous fluctuations due to various factors.